The DPP9-rearrangements resulted in loss of the active sites of DPP9; it is well known that gene fusions may represent loss-of-function events which play a role in carcinogenesis, as reported in colorectal [40] and prostate cancer [41]. This evidence concerns the gene DPP9 and prostate carcinoma.